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Background: Probiotics, especially in combination with non-digestible oligosaccharides, may balance the gut
microflorawhile multistrain preparations may express an improved functionality over single strain cultures. In
vitro gastrointestinal models enable to test survival and growth dynamics of mixed strain probiotics in a
controlled, replicable manner.
Methods: The robustness and compatibility of multistrain probiotics composed of bifidobacteria and
lactobacilli combined with mixed prebiotics (galacto-, fructo- and xylo-oligosaccharides or galactooligosac-
charidesandsolublestarch)werestudiedusingadynamicgastrointestinaltractsimulator(GITS).Theexposure
to acid and bile of the upper gastrointestinal tract was followed by dilution with a continuous decrease of the
dilution rate (de-celerostat) to simulate the descending nutrient availability of the large intestine. The bacterial
numbers and metabolic products were analyzed and the growth parameters determined.
Results: The most acid- and bile-resistant strains were Lactobacillus plantarum F44 and L. paracasei F8.
Bifidobacterium breve 46 had the highest specific growth rate and, although sensitive to bile exposure,
recovered during the dilution phase in most experiments. B. breve 46, L. plantarum F44, and L. paracasei F8
were selected as the most promising strains for further studies.
Conclusions: De-celerostat cultivation can be applied to study the mixed bacterial cultures under defined
conditions of decreasing nutrient availability to select a compatible set of strains.
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T
he human gastrointestinal microbiota is a complex
ecosystem and its balance is crucial for human
health through multiple functions, including nu-
trient digestion and absorption, vitamin synthesis, inhibi-
tion of pathogenic microorganisms, involvement in
energy metabolism, and stimulation of the immune
system (1 3).
Diet and specific nutritional factors have been shown
to shape intestinal microflora and influence health (4 6).
Compared to a Western diet, the ancient food was
significantly less processed and refined, rich in dietary
fibers and live microorganisms. Technological progress in
the food industry (heat treatment, cooling, freezing, etc.)
has resulted in a dramatic decrease of consumption of
food-borne microbes and has coincided with an increased
number of disorders including inflammatory bowel dis-
ease and atopic disorders such as asthma and food aller-
gies (7). Foods and food additives containing probiotics
(living beneficial microbes) may support the restoration
of the healthy balance of the gut microflora (8) while,
compared to single strain probiotics, multistrain prepara-
tions may express an improved functionality by com-
bining benefits of different strains (9, 10). Currently,
Lactobacillus and Bifidobacterium are the most studied
genera regarding such health-promoting properties in
prevention and treatment of various gastrointestinal

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(page number not for citation purpose)disorders, and used in probiotic foods (11, 12). The spe-
cies Bifidobacterium breve, B. longum, B. animalis subsp.
lactis, and B. pseudocatenulatum have been reported as
common inhabitants of the human gut mucosa both in
adults and infants (13).
Dietary fibers, mostly oligo- and polysaccharides that
are not degraded by human digestive enzymes, can
promote the growth of indigenous microorganisms in the
large bowel (2, 14). The fermentation products of these
substrates, that is, short-chain fatty acids (SCFA) con-
tribute positively to normal large bowel function as
energetic substrates for epithelial cells and pH regulators
to enhance scavenging of minerals from colon (15, 16).
To overcome the fiber-deficiency of everyday food, pre-
biotic saccharides can be added to foods or consumed as
dietary supplements. The best-studied prebiotics in-
clude galacto-oligosaccharides (GOS), inulin and fructo-
oligosaccharides (FOS), and lactulose (17, 18).
A synbiotic concept to supply probiotics and prebiotics
within the same product (19) has been reported to support
viability and enhance metabolic activities of probiotic
strains as well as to stimulate indigenous bifidobacteria
and lactobacilli in the gut (20, 21). Thus, the ability to
ferment prebiotics is an important criterion for the selec-
tionofprobioticstrains(22)whileselectivefermentationis
a prerequisite for a prebiotic substance (18).
The survival and metabolic activities towards prebiotic
substrates of the candidate strains of probiotic bacteria
prior to complex animal and human trials can be
evaluated in vitro. A single-vessel dynamic simulator
was developed by Sumeri et al. (23) to study the viability
of probiotic strains under physiological conditions of the
stomach and small intestine. The reliability of a similar
simulator has been confirmed also in comparative in vivo
experiments by Ritter et al. (24). In the current study, a
novel algorithm was introduced to mimic, after the upper
gastrointestinal tract passage, the conditions of the large
intestine by diluting the fermenter content with grad-
ually decreasing rate. The strains L. plantarum F44,
L. paracasei F8, B. breve 46, B. longum 6:18 and B. lactis
8:8, were previously characterized by high tolerance to
acid and bile exposure, strong antimicrobial activity
(AMA) against clinical Clostridium difficile strains in-
cluding the strain NAP1/027, high cell surface hydro-
phobicity and prebiotic degradation capabilities (25, 26).
B. pseudocatenulatum 1200
Twas used as a reference strain
and B. longum 6:18 as a bile sensitive control. The
robustness and compatibility of the multispecies probio-
tics combined with multiple prebiotic substrates were
evaluated to select the most promising combinations for
further studies.
Materials and methods
Strains and culture conditions
Strains of bifidobacteria and lactobacilli (Table 1) for
testing as synbiotic combinations in the gastrointestinal
tract simulator (GITS) were selected on the basis of their
1) acid and bile tolerance, 2) fermentation ability of
specific prebiotic oligosaccharides, and 3) AMA against
pathogenic strains of C. difficile (25). In two-strain co-
cultures in MRS broth no inhibition between the strains
was observed (data not shown).
For biomass preparation, cultures of lactobacilli were
grown in 25 50 mL of De Mann Rogosa Sharp (MRS)
broth (LABM, UK) at 378C. Cultures of bifidobacteria
were grown in 50 100 mL (depending on the cell concen-
tration) MRS broth with 0.05% Cysteine-HCl at 378Ci n
an anaerobic environment (AnaeroGen
TM, Gas Pack
System, Oxoid, Inc., Basingstoke, UK). All cultures for
the GITS experiments were prepared by harvesting the
biomass from overnight cultures by centrifugation and
resuspending the biomass in 10 mL mixture (1:1 vol/vol)
of glycerol and growth medium (MRS with Cysteine-
HCl or MRS broth for bifidobacteria and lactobacilli,
respectively). The cultureswere frozen and kept at  808C
until use.
Table 1. Probiotic strains used in gastrointestinal tract simulator experiments
Experiment no
Strain Source 1a 1b 1c 2a 2b 2c
B. breve 46 LMG P-26117       
B. longum 6:18 LMG P-26115    
B. animalis subsp. lactis 8:8 LMG P-26116      
B. pseudocatenulatum 1200
T JCM 1200   
L. plantarum F44 LMG P-26120       
L. paracasei F8 LMG P-26118    
Carbon sources used in experiments 1a 1c: galactooligosaccharides (GOS), fructooligosaccharides (FOS) and xylooligosaccharides
(XOS), and in experiments 2a 2c: GOS & soluble starch (SS).
B.   Bifidobacterium; L.   Lactobacillus; LMG   culture collection of Lund University and Bacteria Collection of BCCM/LMG; JCM  
Japanese Collection of Microorganisms.
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fuged(10,000rpm/15min,at 48C)toremovetheglycerol
mixture, and the bacterial biomass was resuspended in
a total volume of 200 mL culture medium with oligosac-
charides as shown in Table 2.
Prebiotic substrates
Galacto-, fructo-, and xylooligosaccharides (GOS, FOS
and XOS, respectively) were used as substrates in this
study. Information about the content of mono- and
disaccharides and suppliers of the preparates is presented
in Table 2. While fructo- and galactooligosaccharides are
best-characterized prebiotics, XOS was chosen because of
its high prebiotic potential. The GOS, FOS, and XOS
were dissolved in deionized water and filter-sterilizedwith
syringe filters (0.2 mm, FP 30/0.2 CA-S, Whatman) or
Express
TMPLUS, SteriTop (0.22 mm, Millipore). Soluble
potato starch was mixed with water, heated to 1008C, and
sterilized at 1218C for 15 min. The prebiotic substrates
GOS, FOS, and XOS were used in the experiments no.
1a 1c while mixture of GOS and SS was used in the
experiments no. 2a 2c. Considering the average composi-
tion of the substrates (Table 2), about 5%, that is, 3.2 mM
of the total carbohydrates in GOS, FOS, and XOS were
in form of mono- and disaccharides.
Culture media and additives
The dilution medium contained (g L
 1): tryptone   5,
yeastextract   2.5,Tween 80   0.5, K2HPO4   1, Cys-HCl
  0.5, MgSO47H2O   0.2, MnSO45H2O   0.04, pH
6.590.1 before autoclaving. The mixture of prebiotic car-
bohydratescomprised(gL
 1inthefinalmedium):1)FOS
  3.33, GOS   3.33, XOS   3.33, or2)GOS   5andsoluble
starch   5. Yeast extract and tryptone were purchased
from LABM (UK), phosphate buffer from POCH Che-
micals SA (Gliwice, Poland), Cys-HCl from Merck
(Germany) and MgSO47H2O, MnSO45H2O and Tween
80 from Sigma-Aldrich (US).
Nativeporcinebilewaspooledfrom 10slaughteredpigs
and sterilized through a 0.45 mM filter (VWR Interna-
tional,Stockholm,Sweden)andstoredat  208Cuntiluse
(26). Before use, the bile preparation was thawed and
diluted to 30% (v/v) bile solution with deionized water.
The gastrointestinal tract simulator
The GITS (23) consisted of a 1 L ‘Biobundle’ fermenter
(Applikon Biotechnology, Schiedam, The Netherlands),
a biocontroller ADI 1030 and balances (Sartorius,
Germany) connected to the PC and controlled by
the cultivation program ‘BioXpert’ (Applikon, The
Netherlands). The temperature (378C), pH, culture vo-
lume (V 300 mL), agitation (200 rpm), deaeration
(flushing with N2) and speed rates of liquid pumps (HCl,
NaHCO3, bile salts, feeding medium) were controlled by
this program (Fig. 1).
Two hundred milliliters of suspension of the selected
strains of lactobacilli and bifidobacteria was added into
fermenter containing 100 mL of 0.01M HCl simulating
an empty stomach (27). Secretion of gastric acid was
simulated by adding 1M HCl at a rate of 20 mmol h
 1
(28) to pH  3.0 (about 30 min). The bioreactor content
was then neutralized to pH 6.0 by adding 1 M NaHCO3
at a rate of 4.5 mL min
 1 (approximately 3 5 min),
the 30% porcine bile solution was added at a rate of 4 mL
min
 1 up to concentration of 3% bile in the medium
and incubated under these conditions for 30 min. In the
previous GITS experiments, we have used maximum
0.4% of pure bile salts (Sigma Aldrich, USA) (23, 29)
which lethal effect was found to correlate with about 3%
of porcine bile (data not shown).
The fermenter content was then diluted with the
dilution medium containing prebiotic oligosaccharides,
pH 6.0 with a decreasing rate from D 0.4 h
 1 to
0.04 h
 1 up to the total experiment length of 24 h.
Enumeration of bacteria
The colony forming units of bacteria were determined
from four time-points: the beginning (immediately after
inoculation), 30 min after exposure of maximum bile
concentration, 6.5 and 21 h and from the end (24 h). The
following agar media and incubation conditions were
used: 1) MRS-agar with 0.05% Cysteine-HCl (MRS-C),
anaerobic incubation at 378C, 72 h for total bacterial
Table 2. Composition and supplier of prebiotic oligosaccharides and soluble starch
Carbohydrate source Purity (%) according to specification Other ingredients Supplier
GOS90 PF, powder 96 2.3% lactose, 1.2% glucose, 0.3%
galactose
Friesland Campina
(Amersfoort, Netherlands)
FOS, powder 95 5%: glucose, fructose and sucrose Orafti (Tienen, Belgium)
XOS, powder 95 B5% xylose, arabinose Sweet Town Biotech
(Taipei, Taiwan)
Soluble starch from
potato
100 ND Merck (Darmstadt, Germany)
GOS   galactooligosaccharides; FOS   fructooligosaccharides; XOS   xylooligosaccharides.
Multistrain synbiotics in GITS
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aerobic incubation at 378C for 48 h for lactobacilli.
L. plantarum F44 and L. paracasei F8 could be enumer-
ated selectively on the basis of different colony size on
MRS agar.
Repetitive-PCR (Rep-PCR) analysis
Bacterial DNAwas stored by applying 30 mL of the liquid
culture of a single colony onto FTA Card (Whatman,
Maidstone, UK). For the analyses, the DNA was
extracted from FTA Cards according to the manufac-
turer’s instructions. To specify the strain distribution in
the population, Rep-PCR fingerprinting using (GTG)5
primer (30) as described previously in Sumeri et al. (29)
was performed on average for 30 selected colonies from
the beginning and 30 colonies from the end of each
experiment. The typing (identification) data were extra-
polated onto the whole population (total numbers on
MRS-C agar) to evaluate the proportion of each strain in
the culture.
Determination of organic acids and ethanol
The concentrations of lactate, acetate, formate, and
ethanol in the culture media were determined by li-
quid chromatography (Alliance 2795 system, Waters
Corp., Milford, US), using a BioRad HPX-87H column
(Hercules,CA)withanisocraticelutionof0.005MH2SO4
at a flow rate of 0.6 mL min
 1 and at 358C. Refractive
index (RI, 410 nm) detector (model 2414; Waters Corp.,
US) was used for quantification of organic acids and
ethanol. Samples for HPLC were centrifuged (11,000 g,
5 min), and 0.25 mL of 10% sulfosalicylic acid was added
to 1 mL sample centrifuged and the supernatants decanted
and stored at  208C until analysis. Before injection, the
samples were thawed and centrifuged. Analytical grade
standard substances were used for calibration. Detection
limit of the analytical method was 0.1 mM.
Calculation of growth characteristics
The average specific growth rate of a strain after acid and
bile exposure, that is, during the dilution phase (between
6.5 and 24 h) was calculated as m(strain) D d(N)/
(dt*N), where N is cell count in the fermenter, cfu mL
 1,
D is the dilution rate (1 h
 1), and dt   the time interval
between measurements. Total consumption of carbohy-
drates in hexose equivalents (Cons(hexose), mmol gdw
 1)
was calculated based on the assumption that 2 moles
of acetate, lactate or ethanol are produced per one mole
of hexose (sum of lactate, acetate and ethanol divided
by two). The biomass yield YXS was expressed as dry
biomass (cfu mL
 1 multiplied by the average dry mass
of one cell, i.e., 0.25 pg) produced from total hexose
equivalents.
Results
Dynamics of bifidobacteria and lactobacilli in the
mixed cultures
The robustness and growth dynamics of synbiotic for-
mulations containing lactobacilli, bifidobacteria and
mixed prebiotic substrates was studied using a single
vessel GITS. Three simulation experiments with two
different prebiotic compositions were carried out as
shown in Table 1. The lowest numbers of total colony-
forming units were observed in the samples taken 5 h
after exposure to maximum bile concentration 3% (6.5 h
from the beginning of experiment). For the end of
experiments the total bacterial numbers recovered to or
exceeded the initial numbers, however, with different
strain proportions. Two strains, L. plantarum F44 and
B. breve 46, that were tested with both prebiotic
combinations, form the basis of the comparisons, whilst
L. paracasei F8 was included only in the second prebiotic
set. The impact of B. animalis subsp. lactis 8:8 (experi-
ments 1b, 1c, 2b, 2c), B. longum 6:18 (1a, 1b, 1c) and
B. pseudocatenulatum JCM 1200 (in experiments 2a, 2b)
Fig. 1. Graphic presentation of the changes of acidity (pH), bile concentration (bile) and culture volume (Vc, mL) during 2.5 h of
experiment (a); Decrease of the dilution rate (D) and bile concentration up to 24 h in the simulation experiments (b).
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nificantly lower numbers, thus assumption was made that
three experiments with each prebiotic set can be analyzed
as parallels.
The most robust and competitive strain among bifido-
bacteria was B. breve 46 (Table 3). Previously, this strain
was shown to survive under physiological concentrations
of acid and bile and to metabolize GOS, FOS and SS in
pure culture (25). In the current study, the viable cell
counts of B. breve 46 upon a sequential acid and bile
exposure decreased to about 100 times from 7.2 8.1 to
below 7 log(cfu) mL
 1 (Table 3, experiments no. 1a, 1b,
1c, 2b and 2c). B. breve 46 had the highest average specific
growth rate on both substrate combinations (mave 
0.4390.09 and 0.3390.03 h
 1, in GOS-FOS-XOS and
GOS-SS media, respectively) and recovered during the
dilution phase in all simulations (Table 3). Better average
recovery of B. breve 46 (Change(B46)) was observed in
the medium containing GOS, FOS and XOS (experi-
ments 1a 1c) compared to the medium containing GOS
and SS (48939 vs. 1196.4 times, respectively) (Table 4).
In two experiments (no. 1a and 1c), B. breve 46 was
detected as the dominating strain in the end of dilution.
The B. animalis subsp. lactis strain 8:8 exhibited a
substantial acid and bile tolerance in the screening studies
(25). However, in multistrain cultures, after good sur-
vival during acid and bile exposure the numbers of strain
B 8:8 were around 10
7 cfu * mL
 1 at the end of most
Table 3. Bacterial numbers (expressed as log(cfu mL
 1)) determined by plate counts and corrected according to REP-PCR typing of
the selected isolates
Experiment no,
Strains, log(cfu mL
 1)
sampling point Time, h B46 B88 B1200 F44 F8
1a
Start 0 7.61    8.60  
Bile 30 min 1.5 6.70    8.30  
Dilution 5 h 6.5 6.70    8.08  
End 24 h 24 8.54    8.11  
1b
Start 0 7.77 7.53   8.72  
Bile 30 min 1.5 6.99 6.99   8.55  
Dilution 5 h 6.5 6.94 6.94   8.17  
End 24 h 24 7.43 7.19   8.15  
1c
Start 0 7.20 7.20   8.54  
Bile 30 min 1.5 7.00 ND   8.19  
Dilution 5 h 6.5 6.73 ND   7.98  
End 24 h 24 8.59 ND   8.10  
2a
Start 0    8.79 8.57 8.07
Bile 30 min 1.5    8.12 8.08 7.52
Dilution 5 h 6.5    7.59 7.95 6.62
End 24 h 24    7.70 8.28 8.28
2b
Start 0 7.92 8.10 8.22 8.22 8.34
Bile 30 min 1.5 B7.00 B7.00 B7.00 8.45 8.32
Dilution 5 h 6.5 6.99 6.99 6.99 7.98 8.17
End 24 h 24 7.81 7.00 7.00 7.99 8.49
2c
Start 0 7.55 7.71   8.40 8.63
Bile 30 min 1.5 7.00 B7.00   8.18 8.39
Dilution 5 h 4.5 6.75 7.75   7.34 7.94
End 24 h 24 7.95 7.00   8.50 8.87
Strain names: B46   B. breve 46, B88   B. animalis subsp lactis 88, B1200   B. pseudocatenulatum 1200, F44   L. plantarum F44, F8  
L. paracasei F8.
B10
7   not detected (B10
7 cfu/mL);   strain not used in this experiment.
Multistrain synbiotics in GITS
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other strains because of either lower average specific
growth rate or lower affinity for the substrates compared
to B. breve 46. A similar outcompeting effect was also
observed for strain B. pseudocatenulatum JCM 1200.
Therefore growth characteristics for B. animalis subsp.
lactis8:8andB.pseudocatenulatumJCM1200couldnotbe
calculated. Experiments 1a 1c revealed the acid and bile
sensitivityandpoorsurvivalinmixedculturesofthestrain
B.longum6:18(finalcountsbelow10
7cfu/mL,Table3).As
this strain could not contribute to the overall metabolism
andpopulationdynamics,thedatawerenotincludedinthe
calculations.
The lactobacilli L. plantarum F44 and L. paracasei F8
were previously characterized as robust strains, resistant
to exposure of physiological concentrations of gastric
acid and porcine bile (unpublished data). Our results
showed a sharper decrease in total viable numbers of
lactobacilli during the acid and bile exposure, but better
recovery thereafter in a medium containing GOS and SS
compared to a medium containing GOS, FOS and XOS
(Table 3).
The average specific growth rate of L. plantarum F44
on both sets of prebiotic substrates used in the simulation
experiments was high (mave 0.2690.04 and 0.2790.07
h
 1, for the first and second prebiotic combination,
respectively) and this strain dominated at the end of most
simulations (Tables 3 and 4). This could be explained by
an efficient fermentation of GOS by L. plantarum F44
that is quite atypical trait among lactobacilli. L. paracasei
F8 also survived well the sequential exposure to acid and
bile and was able to grow during the dilution with
prebiotic substrates (Tables 3 and 4).
Metabolism of oligosaccharides
Production of organic acids and ethanol revealed utiliza-
tion of the prebiotic oligosaccharides by the strains
studied (Table 4). Considerable variation of proportions
of lactate, acetate and ethanol was observed between
two substrate combinations. Assuming that two moles of
acid can be produced from one mole of hexose con-
sumed, in average 13% of the total metabolic products
(sum of lactate, acetate, ethanol) could be formed from
mono-and disaccharides of the oligosaccharide prepara-
tions (about 5%, i.e. 3.2 mM of the total carbohydrates,
Table 2).
In pure cultures, L. plantarum F44 metabolized
effectively GOS, FOS and XOS within 24 h, while L.
paracasei F8 showed only avery limited ability to ferment
these substrates, especially GOS during 48 h incubation
(unpublished data). Neither of these lactobacilli fermen-
ted soluble starch. In pure cultures of L. plantarum F44
and L. paracasei F8 (grown 24 h in MRS broth contain-
ing 20 g L
 1 glucose), the molar lactate to acetate ratio
(lac/ace) was higher than two, and that of the bifidobac-
teria was about 0.35, while ethanol was produced only
by bifidobacteria (data not shown). In the multistrain
cultures grown on oligosaccharide media the average
ratio of lactate to acetate was 0.3690.1 that resembles a
typical metabolic pattern of bifidobacteria. The propor-
tion of bifidobacteria (Bif(%)) remained lower in the
GOS-SS medium compared to GOS-FOS-XOS medium
(12.494.4 vs. 52926.1%, respectively) that was accom-
panied by lower average ethanol production per biomass
(41.3913.7 vs. 91.7951.1 mmol gdw
 1, in GOS-SS vs.
GOS-FOS, XOS, respectively, Table 4). As no significant
differences were observed in acetate and lactate forma-
tion, between the two media containing either GOS-SS or
GOS-FOS-XOS (for acetate 225.89100.8 vs. 347.89
179.4 mmol/gdw
 1 and for lactate 85.4974.4 vs. 138.79
115.6 mM gdw
 1, respectively, Table 4) the excess of
Table 4. Growth characteristics of probiotic strains in the GITS
experiments, calculated according to data from the dilution
phase (6.5 24 h), after acid and bile exposure
1a, 1b, 1c 2a, 2b, 2c
Experiments
GOS-FOS-XOS GOS-SS
Substrates (total 1%) Average Stdev Average Stdev
Change(B46) 48.1 39.0 11.1 6.4
Change(F44) 1.1 0.2 6.0 7.6
Change(F8) NA NA 18.8 23.6
Bif(%), 24 h 52.7 26.1 12.4 4.4
m, B46, h
 1 0.43 0.09 0.33 0.03
m, F44, h
 1 0.26 0.04 0.27 0.07
m, F8, h
 1 NA NA 0.33 0.09
Lact/(Ace EtOH),
mM/mM
0.29 0.09 0.30 0.18
Yxs, gdw/g(hexose) 0.02 0.01 0.04 0.02
Cons(hexose), mmol/gdw 302.4 180.9 183.8 90.2
Lact, mmol/gdw 138.7 115.6 85.4 74.4
Ace, mmol/gdw 347.8 179.4 225.8 100.8
EtOH, mmol/gdw 91.7 51.1 41.3 13.7
For, mmol/gdw 117.6 52.3 113.6 45.7
Strain names as shown in Table 3.
Change(strain), cfu mL
 1   change of bacterial counts during
the dilution phase (from 6.5 to 24 h), as the final counts divided
by counts in the beginning of dilution; Bif(%), 24 h   proportion
of bifidobacteria from the total bacterial count in the end of
experiment; m, strain, 1/h   average specific growth rate
of a strain between 6.5 and 24 h (dilution phase); YXS, gdw/
g(hexose)   biomass yield per hexose equivalents consumed;
Cons(hexose), mmol/gdw   consumption of the carbohydrates
(in hexose equivalents) per biomass formed; Lact, Ace, For,
EtOH, mmol/gdw   formation of lactate, acetate, formate and
ethanol per dry biomass; hexose   sum of carbohydrates in
hexose equivalents; gdw   dry weight, expressed in grams of dry
bacterial biomass.
NA   not analyzed.
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genase in the GOS-FOS-XOS medium.
AninterestingfindingwasmultiplicationofL.paracasei
F8 to high cell numbers in the medium containing GOS
and SS, the substrates poorly or not metabolized by this
strain in pure cultures. This indicates a possible cross-
feeding phenomenon byother strains, capable of releasing
monomers from these oligo- and polysaccharides.
Discussion
Compared to conventional chemostat cultures the de-
celerostat technology enables better simulation of a con-
tinuous decrease of the bile concentration (from 3 to
0.001%), exhaustion of substrates and decrease of the
movement rate of the luminal content in the gastrointes-
tinal tract (from 0.4 to 0.04 h
 1), and thus, better mimics
natural competition for substrates. Twenty four hourswas
chosen as an optimal time for the simulation experiments
since a considerable inter-individual variability of the
whole gut transit times with an average of 24 h for men
and about 50 h for women has been reported (31).
Bacterial growth is mediated mostly by substrate
availability and pH of the environment and in vivo, each
segment of the gut has a different composition and
acidity (32, 28). The pH of the gut lumen, varying from
5.5 to 7.5, is likely to be a key factor that determines the
dynamics of the microbial community of the human
colon (33, 34). For example, Cinquin et al. (35) showed
that a more acidic pH accelerated the growth of
Bifidobacterium spp. (7 vs. 9.8 log CFU mL
 1 at pH 6.8
and 5.7, respectively), whereas a more basic pH (6.9 7.5)
decreased the numbers of Lactobacillus spp. (7.7 5.9
log CFU/mL) and increased the Bacteroides cell counts
(6.9 8.2 log CFU/mL) in continuous cultures. Another
study with a fecal microflora and FOS as the primary
carbon and energy source revealed that lactobacilli can
use FOS and outcompete bifidobacteria at pH 5.2 5.4
while in batch fermentations with pure cultures at
pH 6.5 with FOS as a single substrate, bifidobacteria
grew faster than lactobacilli (36). Thus the constant
pH 6.0 kept in our model during the whole dilution
phase, was supposed to give equal growth possibilities for
both bifidobacteria and lactobacilli.
Microbial fermentation in the human colon is con-
sidered to be energy rather than nitrogen limited. In our
experiments the dilution medium containing different
oligosaccharides (GOS, XOS, FOS, or SS) with a total
amount of 10 g L
 1 as carbon sources was used. Similar
quantities of energetic substrates have been reported by
others in batch culture studies (20) and continuous
culture experiments with intestinal bacteria (33).
To elucidate the growth and competition processes
occurring in complex microbial populations, charac-
terization of simple mixed cultures is essential. Beside
environmental parameters such as acidity variations and
substrate limitation, the strain balance and activities of
microorganisms are determined by an interplay between
consortium members like antagonism, competition for
substrates, or symbiosis by cross-feeding (37). As cross-
feeding between bifidobacteria and butyrate producing
bacteria in colon has been shown, the same phenomenon
obviously exists between other phyla. Our co-culture
experiments (unpublished data) as well as the current
study reveal that growth of L. paracasei F8 is enhanced in
presence of B. breve 46.
In the GOS-FOS-XOS supplemented medium (Experi-
ments 1a 1c), bifidobacteria comprised about half of
total population at the end of experiments (52926%)
while in the GOS-SS containing medium (Experiments
2a 2c) proportion of bifidobacteria was significantly
lower (12.494.4%, Table 4). It can be explained by lower
growth rate of B. breve 46 in GOS-SS medium (0.33
versus 0.43 h
 1 in GOS-FOS-XOS medium), whilst the
growth rate of lactobacilli was comparable in both media
(0.2690.04, and 0.2790.07 h
 1 for F44, and 0.3390.09
h
 1 for F8 in GOS-SS, Table 4). Another explanation of
lower proportion of bifidobacteria (higher proportion of
total lactobacilli) in medium containing GOS and SS
could be inclusion of the strain L. paracasei F8 in
experiments 2a 2c (GOS-SS), which was not used in
experiments 1a 1c (GOS-FOS-XOS). The ability to
metabolize various oligosaccharides in pure culture and
high AMA against C. difficile in in vitro experiments
suggest the strain B. longum 6:18 as a potential probiotic
if protected, for example by encapsulation to survive
passage through the upper gastrointestinal tract.
The metabolism of prebiotic oligosaccharides is
species- and strain-specific depending on their composi-
tion, structure (linkage types, branching) and degree of
polymerization (38 41). Metabolism of mono-, di- and
trisaccharides is generally faster and energetically less
costly for bifidobacteria and lactobacilli compared to
substrates with DP 3 (42, 43). Growth substrates may
influence the metabolic features in proteome and meta-
bolome as well as survival under gastrointestinal condi-
tions (41). Van der Meulen et al. (44) studied the growth
of bifidobacteria on different energy sources and showed
that glucose was consumed with the highest rate and
oligofructose with the lowest rate by strain B. longum
BB536 (specific sugar consumption rate 3.5 vs. 1.3 mmol
CDM
 1 h
 1) while for the strain B. animalis subsp. lactis
Bb-12 the fastest consumption of lactose and slowest for
oligofructose were observed (3.9 vs. 0.5, respectively).
Under carbon-limited anaerobic growth conditions
like the environment of the large intestine, lactate,
acetate, formate and ethanol can be produced by both
bifidobacteria and lactobacilli. In the simulated large
intestine studies of Cinquin et al. (35), acetate produc-
tion positively correlated with the concentration of
bifidobacteria (R 0.76, PB0.05) suggesting acetate
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theoretically yields two lactate and three acetate from
two hexose molecules. Our study revealed correlation
between higher proportion of bifidobacteria, acetate
concentration as well as ethanol production (Table 4).
That is in agreement with the pure culture data.
Based on the product and biomass formation and the
contents   about 5%   of readily available free sugars
(mono- and disaccharides) in oligosaccharide prepara-
tions (Table 2), on average 47 48% of total carbohydrates
available (10 g L
 1) were metabolized during 24 h,
suggesting that the differences in growth characteristics
in two different media resulted clearly from differences of
oligosaccharide metabolism by lactobacilli and bifidobac-
teria.Thetotalbiomassyieldpercarbohydratesconsumed
(YXS) was less than 4%, while about two times lower
average YXS which coincided with more intensive product
formation (lactate, acetate, ethanol) was observed in
GOS-FOS-XOS compared to GOS-SS medium (Table
4).However,similarratiosoflactate/(acetate ethanol)in
both media suggest similar ATP production and NAD
 
regeneration strategies of the cells in both media.
The largest limitation of the current system is the
absence of the complex microbiota of the large intestine
since the main objective of the current study was to select
themostrobuststrainsinregardtoacidandbileresistance
that are able to grow synergistically on the selected
prebiotic substrates. Co-fermentations of the selected
synbioticcombinationswiththefecalmicrofloraandother
carbon sources will be considered in future studies.
We have shown that a single vessel de-celerostat based
GITS can be used to study the survival, recovery and
dynamics of mixed bacterial cultures under changing
environmental conditions of gastrointestinal tract. As a
result of this study, B. breve 46, L. plantarum F44, and
L. paracasei F8 as the most resistant strains against acid
and bile exposure able to grow synergistically in mixed
culture were selected for further evaluation. For better
understanding of the concomitant influence of pH,
dilution rate and medium composition on metabolism
of oligosaccharides in mixed cultures of bifidobacteria
and lactobacilli, also steady state cultivations with the
dynamic changes of dilution rate, pH or substrate ratios
should be carried out.
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